172 related articles for article (PubMed ID: 34583669)
1. Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study.
Kawashita Y; Kitamura M; Soutome S; Ukai T; Umeda M; Saito T
BMC Cancer; 2021 Sep; 21(1):1064. PubMed ID: 34583669
[TBL] [Abstract][Full Text] [Related]
2. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
3. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa].
Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF
Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474
[TBL] [Abstract][Full Text] [Related]
4. The Role of Pretreatment Serum Neutrophil-to-Lymphocyte Ratio in Hypopharyngeal Cancer Treated with Definitive Chemoradiotherapy: A Pilot Study.
Kuo C; Hsueh WT; Wu YH; Yang MW; Cheng YJ; Pao TH; Tsai MH
Sci Rep; 2019 Feb; 9(1):1618. PubMed ID: 30733592
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
Kano S; Homma A; Hatakeyama H; Mizumachi T; Sakashita T; Kakizaki T; Fukuda S
Head Neck; 2017 Feb; 39(2):247-253. PubMed ID: 27617428
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
[No Abstract] [Full Text] [Related]
8. Preoperative Neutrophil-to-lymphocyte Ratio Predicts Long-term Survival in Patients Undergoing Total Laryngectomy With Advanced Laryngeal Squamous Cell Carcinoma: A Single-center Retrospective Study.
Fu Y; Liu W; OuYang D; Yang A; Zhang Q
Medicine (Baltimore); 2016 Feb; 95(6):e2689. PubMed ID: 26871799
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.
Zeng YC; Chi F; Xing R; Xue M; Wu LN; Tang MY; Wu R
Jpn J Clin Oncol; 2016 Feb; 46(2):126-31. PubMed ID: 26611205
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.
Ki Y; Kim W; Nam J; Kim D; Park D; Kim D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):393-8. PubMed ID: 19362778
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
13. Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.
Sumner WA; Stokes WA; Oweida A; Berggren KL; McDermott JD; Raben D; Abbott D; Jones B; Gan G; Karam SD
J Transl Med; 2017 Aug; 15(1):168. PubMed ID: 28764811
[TBL] [Abstract][Full Text] [Related]
14. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
15. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
16. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
17. Preoperative neutrophil-to-lymphocyte ratio as prognostic predictor for hypopharyngeal squamous cell carcinoma after radical resections.
Song Y; Liu H; Gao L; Liu X; Ma L; Lu M; Gao Z
J Craniofac Surg; 2015 Mar; 26(2):e137-40. PubMed ID: 25643330
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy with fraction size of 2.25 Gy in T1-2 laryngeal and hypopharyngeal cancer.
Karasawa K; Kunogi H; Hirai T; Hoji H; Hirowatari H; Izawa H; Ito K; Sasai K; Furuya T; Ozawa S; Matsumoto F; Ito S; Oba S
J Radiat Res; 2013 Jul; 54(4):684-9. PubMed ID: 23297315
[TBL] [Abstract][Full Text] [Related]
20. Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy.
Palomar-Abril V; Soria-Comes T; Campos ST; Ureste MM; Bosch VG; Maiques ICM
Clin Transl Oncol; 2020 Dec; 22(12):2333-2340. PubMed ID: 32449125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]